Disease Awareness Ads Indistinct From Product Ads Could Be Viewed As Promotional, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Non-branded ads should be “separate and distinct” from product-specific ads, FDA Regulatory Counsel Kristin Davis says.
You may also be interested in...
FDA Extends Comment Period For Direct-To-Consumer Advertising Guidances
The agency has reopened the comment period until Aug. 10 to allow additional time for conducting DTC research, Ad Division Director Tom Abrams says. FDA plans to conduct its own research on the content and format of the brief summary.
Alternatives To Brief Summary Outlined In Draft Guidance
One of FDA's three draft guidances on DTC advertising requests that consumer-friendly language be used. Commissioner McClellan calls proposed brief summary alternatives a "win-win" and suggests manufacturers will be able to reduce their advertising costs as a result.
U.S. Patents Could Limit President's AIDS Drug Assistance Plan, GAO Says
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.